Synapse - Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study Meeting Abstract

Authors:	Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; Werner, K.; Rispoli, J.; Caple, J.; Sams, A.; Verducci, D.; Jones, K.; Concepcion, I.; Amanda, C.; Chansakul, A.; Schlossman, J.; Tavitian, E.; Shekarkhand, T.; Harrison, A.; Piacentini, C.; Rustad, E. H.; Yellapantula, V.; Maura, F.; Landau, H. J.; Scordo, M.; Chung, D. J.; Shah, G.; Lahoud, O. B.; Thoren, K.; Murata, K.; Ramanathan, L.; Arcila, M. E.; Ho, C.; Roshal, M.; Dogan, A.; Derkach, A.; Giralt, S. A.; Korde, N.
Abstract Title:	Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study
Meeting Title:	62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	136
Issue:	Suppl. 1
Meeting Dates:	2020 Dec 5-8
Meeting Location:	Virtual
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2020-11-05
Language:	English
ACCESSION:	WOS:000607547202140
DOI:	10.1182/blood-2020-142466
PROVIDER:	wos
Notes:	Meeting Abstract: 7 -- Amanda Ciardello's first and last name is swapped in publisher record -- Kelly Werner appears as Kelly Barnett in Synapse -- Source: Wos